Stock listing
NASDAQ:OLMA Olema Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Olema Pharmaceuticals, Inc.
Follow Olema Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:OLMA
$7.00 USD -0.33 (-4.5%)
Close on Oct 30, 2026
- Day range
- $6.92 – $7.42 USDOct 30, 2026
- Volume
- 751,077 sharesOct 30, 2026
- Market cap
- $612.5M USDAt the close on Oct 30, 2026 · price × 87.50M shares outstanding
- 52-week range
- $6.24 – $36.26 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $10.72M USDMedian day 1.07M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:OLMA · Home | $7.00 USD | -0.33 (-4.5%) | 751,077 | $7.22 | $7.42 | $6.92 | $7.33 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:OLMA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.00 | -0.33 | -4.5% | $7.22 | $7.42 | $6.92 | 751,077 | |
| $7.33 | -0.16 | -2.1% | $7.47 | $7.59 | $7.14 | 1,153,497 | |
| $7.49 | +0.45 | +6.4% | $6.93 | $7.49 | $6.81 | 1,437,507 | |
| $7.04 | +0.42 | +6.3% | $6.62 | $7.13 | $6.49 | 2,190,088 | |
| $6.62 | +0.21 | +3.3% | $6.44 | $6.78 | $6.34 | 1,987,370 | |
| $6.41 | -0.61 | -8.7% | $6.93 | $6.94 | $6.235 | 1,984,600 | |
| $7.02 | -0.03 | -0.4% | $6.96 | $7.10 | $6.83 | 1,064,900 | |
| $7.05 | -0.20 | -2.8% | $7.24 | $7.47 | $7.03 | 1,236,200 | |
| $7.25 | +0.14 | +2.0% | $7.12 | $7.61 | $7.085 | 1,871,500 | |
| $7.11 | +0.53 | +8.1% | $6.68 | $7.255 | $6.68 | 1,272,600 | |
| $6.58 | -0.29 | -4.2% | $6.83 | $6.83 | $6.48 | 1,081,300 | |
| $6.87 | +0.07 | +1.0% | $6.84 | $6.945 | $6.70 | 1,088,400 | |
| $6.80 | -0.22 | -3.1% | $6.92 | $7.15 | $6.61 | 1,845,300 | |
| $7.02 | -0.34 | -4.6% | $7.30 | $7.363 | $6.99 | 2,013,800 | |
| $7.36 | -0.46 | -5.9% | $7.77 | $7.77 | $7.33 | 1,018,700 | |
| $7.82 | 0.00 | 0.0% | $7.77 | $8.00 | $7.725 | 758,200 | |
| $7.82 | -0.12 | -1.5% | $7.87 | $8.21 | $7.56 | 1,400,200 | |
| $7.94 | +0.02 | +0.3% | $7.90 | $8.23 | $7.79 | 819,200 | |
| $7.92 | -0.33 | -4.0% | $8.28 | $8.29 | $7.80 | 1,038,900 | |
| $8.25 | +0.025 | +0.3% | $8.28 | $8.30 | $7.85 | 1,006,100 | |
| $8.225 | -0.045 | -0.5% | $8.39 | $8.52 | $8.10 | 1,071,900 | |
| $8.27 | -0.37 | -4.3% | $8.58 | $8.66 | $8.19 | 1,009,500 | |
| $8.64 | +0.10 | +1.2% | $8.59 | $8.86 | $8.42 | 1,542,800 | |
| $8.54 | -0.07 | -0.8% | $8.60 | $8.73 | $8.46 | 1,079,600 | |
| $8.61 | -0.14 | -1.6% | $8.71 | $8.85 | $8.40 | 979,200 | |
| $8.75 | -0.29 | -3.2% | $9.04 | $9.04 | $8.57 | 1,382,700 | |
| $9.04 | +0.21 | +2.4% | $8.79 | $9.27 | $8.59 | 1,486,100 | |
| $8.83 | -0.81 | -8.4% | $9.64 | $9.64 | $8.70 | 1,642,200 | |
| $9.64 | +0.01 | +0.1% | $9.66 | $9.815 | $9.56 | 1,490,500 | |
| $9.63 | -0.19 | -1.9% | $9.95 | $10.13 | $9.61 | 1,069,600 | |
| $9.82 | -0.08 | -0.8% | $9.88 | $9.93 | $9.75 | 3,061,400 | |
| $9.90 | +0.17 | +1.7% | $9.89 | $10.35 | $9.73 | 1,087,900 | |
| $9.73 | -0.05 | -0.5% | $9.86 | $9.93 | $9.44 | 1,246,300 | |
| $9.78 | -0.51 | -5.0% | $10.29 | $10.34 | $9.65 | 1,733,100 | |
| $10.29 | +0.07 | +0.7% | $9.99 | $10.37 | $9.79 | 1,822,800 | |
| $10.22 | -0.47 | -4.4% | $10.79 | $10.86 | $10.18 | 1,013,500 | |
| $10.69 | +0.33 | +3.2% | $10.19 | $10.98 | $10.11 | 1,116,300 | |
| $10.36 | -0.625 | -5.7% | $11.13 | $11.18 | $10.35 | 863,400 | |
| $10.99 | +0.235 | +2.2% | $10.61 | $11.06 | $10.46 | 736,700 | |
| $10.75 | +0.02 | +0.2% | $10.61 | $10.85 | $10.57 | 505,300 | |
| $10.73 | -0.10 | -0.9% | $10.71 | $10.98 | $10.58 | 773,300 | |
| $10.83 | +0.27 | +2.6% | $10.58 | $11.02 | $10.48 | 866,400 | |
| $10.56 | +0.13 | +1.2% | $10.36 | $10.63 | $10.28 | 766,100 | |
| $10.43 | +0.16 | +1.6% | $10.20 | $10.53 | $10.09 | 937,000 | |
| $10.27 | -0.52 | -4.8% | $10.69 | $10.77 | $10.19 | 740,800 | |
| $10.79 | -0.06 | -0.6% | $10.70 | $10.92 | $10.62 | 383,300 | |
| $10.85 | -0.06 | -0.5% | $10.78 | $10.97 | $10.58 | 471,900 | |
| $10.91 | +0.48 | +4.6% | $10.60 | $11.02 | $10.60 | 799,924 | |
| $10.43 | -0.26 | -2.4% | $10.58 | $10.62 | $10.29 | 727,325 | |
| $10.69 | -0.21 | -1.9% | $10.90 | $11.24 | $10.65 | 748,500 | |
| $10.90 | -0.41 | -3.6% | $11.10 | $11.12 | $10.67 | 1,039,100 | |
| $11.31 | +0.66 | +6.2% | $10.90 | $11.36 | $10.77 | 1,757,800 | |
| $10.65 | -0.12 | -1.1% | $10.69 | $10.88 | $10.51 | 960,500 | |
| $10.77 | +0.14 | +1.3% | $10.61 | $10.95 | $10.51 | 889,900 | |
| $10.63 | +0.12 | +1.1% | $10.44 | $10.75 | $10.29 | 1,163,100 | |
| $10.51 | +0.07 | +0.7% | $10.36 | $10.62 | $10.27 | 1,152,100 | |
| $10.44 | +0.01 | +0.1% | $10.50 | $10.70 | $10.28 | 1,301,300 | |
| $10.43 | -1.51 | -12.6% | $10.98 | $11.28 | $9.70 | 2,671,324 | |
| $11.94 | -0.11 | -0.9% | $11.92 | $12.20 | $11.70 | 724,110 | |
| $12.05 | +0.25 | +2.1% | $11.93 | $12.21 | $11.87 | 757,200 | |
| $11.80 | +0.22 | +1.9% | $11.51 | $12.21 | $11.50 | 747,900 | |
| $11.58 | -0.18 | -1.5% | $11.82 | $11.97 | $11.43 | 722,400 | |
| $11.76 | +0.48 | +4.3% | $11.50 | $11.96 | $11.30 | 1,217,500 | |
| $11.28 | -0.17 | -1.5% | $11.85 | $11.85 | $11.02 | 763,700 | |
| $11.45 | -0.37 | -3.1% | $11.77 | $11.87 | $11.37 | 709,800 | |
| $11.82 | +0.63 | +5.6% | $11.25 | $11.84 | $11.02 | 689,300 |
- Ticker
- NASDAQ:OLMA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 40 slides
Latest news
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $8.25 (+0.3%) on Oct 5, 2026
Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer
Aug 13, 2026
Closed $10.51 (+0.7%) on Aug 13, 2026
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
Aug 10, 2026
Closed $10.43 (-12.6%) on Aug 11, 2026
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
May 26, 2026
Closed $13.55 (-1.0%) on May 26, 2026
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026
Closed $13.68 (-2.7%) on May 22, 2026
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
May 12, 2026
Closed $13.97 (-6.0%) on May 12, 2026
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
Apr 29, 2026
Closed $14.41 (+1.9%) on Apr 30, 2026
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
Apr 21, 2026
Closed $16.24 (-2.3%) on Apr 22, 2026
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Apr 17, 2026
Closed $16.58 (-1.4%) on Apr 20, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 40 slides · August 2026
Investor Presentation (January 2026)
Investor deck · 39 slides · Jan 12, 2026
Investor Presentation (October 2025)
Investor deck · 39 slides · Oct 20, 2025
Investor Presentation (August 2025)
Investor deck · 37 slides · Aug 11, 2025
Olema Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 117 in all · newest Nov 2, 2026 · oldest 2020
- Decks
- 14 decks · latest August 2026
Where Olema Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:OLMA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:OLMA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Olema Pharmaceuticals, Inc.